Results: Effect size for desire: 0.49 to 0.61 Effect size for distress reduction: 0.60 to 0.62 25% of treated patients versus 17% placebo achieved clinically meaningful desire increase 35% versus 31% achieved clinically meaningful distress reduction A 52-week open-label extension confirmed sustained efficacy and safety (PMC6819021, PMC6819023)
Men and women can both benefit from Sermorelins effects, including healthier skin, hair growth, better workouts, sleep hygiene, faster recovery, and more
Newer peptide-based therapies aim to support insulin signaling, regulate appetite, and improve tissue responsiveness by engaging physiological pathways involved in metabolic control
Yes, glutathione is safe when administered under the vigilant supervision of healthcare professionals
Compounding of semaglutide will continue until at least May 22, 2025, for 503B Pharmacies (also known as 503B Outsourcing Facilities, which are compounding pharmacies that can produce large batches of medications without patient-specific prescriptions)
